Description
What is TAGRISSO:
Tagrisso is a medicine that contains the active substance Osimertinib and is available as tablets.
Tagrisso – Osimertinib 80 mg and 40 mg is supplied for Tenders, Emergency imports, Orphan drug, Reference listed drugs, Comparator Drug, Name patient medicine, Bio-Similar and Innovator samples etc.
In how many countries TAGRISSO is approved for marketing:
TAGRISSO is available/approved in the USA and Europe. We can help you to access it in India.
What is TAGRISSO used for:
TAGRISSO is indicated for the treatment of patients with metastatic epidermal growth factor receptor (EGFR) T790M mutation positive non-small cell lung cancer (NSCLC).
How can I get TAGRISSO in India?
TAGRISSO is a prescription only drug and is not approved for marketing in India.
The Indian Pharma (IP) is a consulting pharmaceutical company which assists Patients in accessing medicines in India. The Indian Pharma facilitates such access only against valid prescriptions in conformity with all local laws and regulations.
Patients/ Clinicians / Researchers can contact Please Call/WhatsApp:+91 8130290915 or dial our TOLL-FREE Number: 1800-889-1064 or write to at –info@theindianpharma.com
We facilitate by :-
- Helping in documentation to import the medicine for personal use
- Finding Genuine and reliable source in USA, Europe and Japan
- Ensuring 100% transparency.
TAGRISSO can be shipped to Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Jaipur, Lucknow, Cochin and Pune and other cities in India.
The Indian Pharma can facilitate the supply of TAGRISSO (prescription medicines) to all locations in the world and in India after fulfilling the legal requirement.
The Indian Pharma does not manufacture, supply, re-sell or retail any drugs or medicines. All trademarks and other intellectual property in relation to drugs and medicines supplied to you by suppliers are owned by their respective manufacturers or licensees
Can I get TAGRISSO even if I am not based in India?
Almost all countries across the world have provisions for granting access to drugs prior to marketing approval for personal use for patients who have exhausted all other treatment options available in their country
The Indian Pharma (IP) can help patients in accessing/importing TAGRISSO, unapproved in their home country against a legitimate prescription and in conformity with all local laws and regulations of their home country.
Send your inquiry to find-
- TAGRISSO in South East Asia – China (Beijing, Chongqing, Shanghai, Tianjin and Shenzhen), Cambodia, Indonesia, Malaysia, the Philippines, Singapore, Thailand, Vietnam, Hong Kong.
- TAGRISSO in United Arab Emirates – Iraq, Iran, Saudi Arabia, Jordan.
- TAGRISSO in North America – Mexico.
- TAGRISSO in South America – Argentina, Brazil, Chile, Colombia, Peru, Venezuela.
- TAGRISSO in Europe – Romania, Switzerland, Georgia, Turkey, Italy, UK, Ukraine, Azerbaijan, Latvia, Poland, Slovakia.
- TAGRISSO in Russia CIS – Armenia, Kazakhstan, Moldova, Tajikistan, Turkmenistan, Uzbekistan, Mongolia.
- TAGRISSO in African Countries – Algeria, Mauritius, Uganda, Zimbabwe.
- TAGRISSO in Australia and New Zealand.